FCT
GILD icon

Family Capital Trust’s Gilead Sciences GILD Stock Holding History

Family Capital Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-126
Closed -$13K – 70
2015
Q4 		$13K Hold
126
– – 0.01% 67
2015
Q3 		$12K Hold
126
– – 0.01% 76
2015
Q2 		$15K Buy
+126
New +$13.8K 0.01% 81

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Family Capital Trust's GILD Position: Q1 2016 in Review

Family Capital Trust sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 126 shares — an estimated $13K sold.

Family Capital Trust first reported a position in GILD in Q2 2015 and held it in 3 quarters. The position peaked at $15K in Q2 2015. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Family Capital Trust reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Family Capital Trust sold 126 Gilead Sciences shares in Q1 2016, an estimated $13K.
  • Family Capital Trust first reported a position in Gilead Sciences in Q2 2015 and held it in 3 quarters.
  • Family Capital Trust's Gilead Sciences position peaked at $15K in Q2 2015.
  • 1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Family Capital Trust's 13F filing for Q1 2016, filed 22 Apr 2016.